Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-454-9 | CAS number: 818-61-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity (OECD TG 401), LD50 = 540 mg/kg bw
Acute dermal toxicity (OECD TG 402), LD50 > 1000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- Groups of 5 male Sherman rats were administered doses of 126, 252, 500, 1000, and 2000 mg/kg bw by gavage. The animals were observed for lethality, changes in general appearance and demeanor and body weight gain during a 14-day post-exposure period.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sherman
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Fasting period before study: yes
ENVIRONMENTAL CONDITIONS
no details - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 10 % - Doses:
- 126, 252, 500, 1000, and 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: no data
- Other examinations performed: clinical signs, body weight - Statistics:
- Weil CS (1952). Biometrics 8: 249-263
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 540 mg/kg bw
- 95% CL:
- >= 390 - <= 750
- Mortality:
- At the highest dose of 2000 mg/kg bw 5/5 rats died within 2-24 hrs after dosing. At the doses of 1000 and 500 mg/kg bw 2/5 rats died within 24 hrs after administration. At the two lower doses of 252 and 126 mg/kg bw, no mortality occurred.
- Clinical signs:
- other: No changes in general appearance and demeanor were observed among any of the surviving animals.
- Interpretation of results:
- Category 4 based on GHS criteria
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 540 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): 2-Hydroxyethyl acrylate
- Analytical purity: 99.1 area % (GC)
- Lot/batch No.: Beh. 11, 15 :30
- Substance No.: 98/184-1 - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Boehringer Ingelheim Pharma KG
- Strain: Wistar / chbb: thom (SPF)
- Age at study initiation: young adult animals
- Weight at study initiation: 200 g - 300 g (± 20 % of the mean weight)
- Fasting period before study: no fasting
- Housing: single housing
- Diet (ad libitum): Labordiaet, Klingentalmuehle AG, Kaiseraugst, Switzerland
- Water (ad libitum): tap water
- Acclimation period: at least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature: 20 - 24 °C
- Humidity: 30 - 70 % relative humidity
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- semiocclusive
- Vehicle:
- olive oil
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorsal and dorsolateral parts of the trunk (clipped)
- Application area: 50 cm2 (corresponds to at least 10 % of the body surface area)
- Type of wrap if used: The bandage consisted of four layers absorbent gauze, Ph. Eur. Lohmann GmbH & Co. KG and Fixomull stretch (adhesive
fleece), Beiersdorf AG
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes, with warm water
- Time after start of exposure: 24 hrs
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.36 mL/kg bw (undiluted, 400 mg/kg bw) and as an emulsion 4.0 mL/kg bw (1000 mg/kg bw)
- Concentration (if solution): 25 g / 100 mL (dose: 1000 mg/kg bw)
- Constant volume or concentration used: yes/no
VEHICLE
- Amount(s) applied (volume or weight with unit): 4.0 mL/kg bw emulsion
- Lot/batch no.: DAB 10 - Duration of exposure:
- 24 hrs
- Doses:
- 400 and 1000 mg/kg bw
- No. of animals per sex per dose:
- 400 mg/kg bw: 5 males, 5 females; 1000 mg/kg bw: 5 males
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Individual body weights were determined shortly before application (day 0), weekly thereafter and at the end of the study (before fasting period). Recording of signs and symptoms was performed several times on the day of administration, and at least once each workday for the individual animals. A check for any dead or moribund animal was made twice each workday and once on saturdays, sundays and on public holidays.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, histopathology, scoring of skin findings according to Draize JH (1959) (Appraisal of the safety of chemicals in foods, drugs and cosmetics. The association of food and drug officials of the United States Austin, Texas) - Statistics:
- no data
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 mg/kg bw
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: No systemic signs of toxicity were noted in any animals.
- Gross pathology:
- Necropsy findings noted in the animals sacrificed at the end of the study comprised: focal lesion with incrusted surface of the skin (400 mg/kg bw), lesion or necrosis of the skin in the region of application area (1000 mg/kg bw). Histopathological examination of 1 animal of the 1000 mg/kg bw dose group revealed focal necrosis (full thickness necrosis), perifocal hyperplasia, squamous cell and perifocal inflammation.
- Other findings:
- - Local skin findings: The following local effects, observed in the 400 and 1000 mg/kg bw dose groups comprised very slight, well-defined and moderate to severe erythema, very slight, slight and moderate edema, scaling, severe scaling, crust formation, bleeding (in some cases extending beyond the area of exposure), petechiae extending beyond the area of exposure, ulcer, alopecia, erosion and eczematoid skin change (in one case extending beyond the area of exposure). Visual necrosis was observed in 2 female animals of the 400 mg/kg bw dose group and in 4 male animals of the 1000 mg/kg bw dose group.
- Interpretation of results:
- Category 4 based on GHS criteria
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Justification for type of information:
- Please see for more information the read-across justification in Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 mg/kg bw
- Remarks on result:
- other: Result read-across CAS 25584-83-2
Referenceopen allclose all
Under the conditions of this study the acute dermal median lethal dose (LD50) of 2 -Hydroxyethyl acrylate was found to be greater than 1000 mg/kg body weight for the male animals. Due to animal welfare reason (necrosis of the skin) the other sex was not tested. In a study performed in parallel with the similar test substance Hydroxypropyl acrylate (Project-No. 11A0185/981043) no mortality occurred after application of 1000 mg/kg body weight to 5 female animals. Therefore the acute dermal median lethal dose (LD50) of 2 -Hydroxyethyl acrylate is considered to be greater than 1000 mg/kg body weight for the male and female animals.
Body weights [g]:
Dose [mg/kg bw] |
400 |
1000 |
|
male |
female |
male |
|
Day 0 |
250 |
230 |
270 |
Day 7 |
270 |
232 |
273 |
Day 13 |
302 |
248 |
305 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 000 mg/kg bw
Additional information
Oral exposure route:
There are several valid studies available that are acceptable for assessing the acute oral toxicity of 2-hydroxyethyl acrylate in rats.
The key acute toxicity oral study was performed with Sherman rats (Dow Chem. Co., 1980). Groups of 5 male Sherman rats were administered doses of 126, 252, 500, 1000, and 2000 mg/kg bw by gavage. The animals were observed for lethality, changes in general appearance and demeanor and body weight gain during a 14-day post-exposure period. No data were given concerning clinical signs or necropsy findings and LD50 was determined to be 540 mg/kg bw with 95 % confidence limits of 390 to 750.
In another acute toxicity study conducted by BASF (1974) according to an internal protocol comparable to the OECD TG 401 groups of 5 Sprague-Dawley rats/sex/dose were administered doses of approx. 202, 404, 809, 1137, and 1618 mg/kg bw by gavage and observed for 7 days for lethality and clinical signs of intoxication. The mortality rate was 0/10, 0/10, 3/10, 7/10, and 10/10 in the low, mid and high dose groups, respectively. The LD50 was found to be approx. 960.5 mg/kg bw. Clinical symptoms were unspecific: dyspnoea, slight apathy, closed eyes, and squatting posture. In the surviving animals, reduction of body weight as compared to weights determined at test start was noted. At necropsy acute dilatation of the right heart chamber, acute congestive hyperemia of the heart, and stomach dilatation with distinctly injected vessels were recorded in the deceased animals. The sacrificed animals of the mid dose group showed at necropsy dilatation of the gastro-oesophageal vestibule, adhesion to the peritoneum, and alterations of the epithelium of the glandular stomach (epithelial foldings plump and irregular). These data indicate, that the substance causes local skin damage in the GI-tract due its corrosivity, which might at least partially be responsible for the effects noted (BASF AG, 1974).
Similar LD50 values were observed in three other studies (Union Carbide Corporation (1966), Smyth et al (1951), and The Dow Chemical Company (1962)).
Based on these test results (LD50 > 500 - < 1000 mg/kg bw), 2-hydroxyethyl acrylate is assessed to be of moderate toxicity after a single ingestion, which might be at least partially due to the local tissue damage.
Dermal exposure route:
The key acute dermal toxicity study of the test substance was a GLP-compliant study according to OECD Guideline 402 (BASF, 1999a). A group of 5 male and 5 female Wistar rats (400 mg/kg bw) and a second group of 5 male rats (1000 mg/kg bw) were tested. The test material was applied in undiluted form (400 mg/kg bw) or as an emulsion in olive oil DAB 10 (1000 mg/kg bw) to the clipped epidermis (dorsal and dorsolateral parts of the trunk) of each animal and was covered by a semi-occlusive dressing for 24 hours. No systemic signs of toxicity were noted in all animals. Local effects, observed in the 400 and 1000 mg/kg bw dose groups comprised very slight, well-defined and moderate to severe erythema, very slight, slight and moderate edema, scaling, severe scaling, crust formation, bleeding (in some cases extending beyond the area of exposure), petechiae extending beyond the area of exposure, ulcer, alopecia, erosion and eczematoid skin change (in one case extending beyond the area of exposure). Visual necrosis was observed in 2 female animals of the 400 mg/kg bw dose group and in 4 male animals of the 1000 mg/kg bw dose group. Although the skin barrier was almost completely destroyed under the given test conditions and severe local skin damage was noted, no mortality occurred. Under the conditions of this study the acute dermal median lethal dose (LD50) of 2-hydroxyethyl acrylate was found to be greater than 1000 mg/kg body weight for the male animals. Due to animal welfare reason (necrosis of the skin) the other sex as well as higher doses were not tested.
In a supporting study performed in parallel with the structural analogue hydroxypropyl acrylate (CAS 25584 -83 -2) no mortality occurred after application of 1000 mg/kg body weight to 5 female animals. Therefore the acute dermal median lethal dose (LD50) of 2-hydroxyethyl acrylate is considered to be greater than 1000 mg/kg body weight for the male and female animals (BASF, 1999).
In addition, there are several older studies with 2-HEA conducted in rabbits which demonstrate without exception a higher toxicity of 2-HEA in rabbits in comparison to rats with LD50 values > 50 - < 200 mg/kg bw (Dow Chemical Company 1980 and 1981, BASF 1979, Union Carbide Corporation 1966). However, 2-hydroxyethyl acrylate is a corrosive substance and is classified and labelled as Skin Corrosion Category 1B, H314. More recent experimental experience has shown that rabbits are quite susceptible to stress, e. g. caused by local skin damage due to the application of corrosive substances like 2-HEA. Emotional stress and intense pain can lead to cardiac failure in rabbits. Therefore it is unclear if death was due to stress as a response to severe local effects, or due to systemic toxicity of the compound.
Lethality was also observed after an exposure period of 4 hours in skin irritation studies with rabbits if undiluted material was tested, whereas no systemic effects were noted if a 10 % solution was applied (Dow, Chemical Company, 1980).
However, assumed that bioavailability after dermal application of 2-HEA was 100 % due to damage of the skin barrier a LD50 value comparable to that after oral administration (100 % bioavailability has been demonstrated (BAMM, 1992)) would be expected. Since there are no indications for interspecies differences in the toxicological profile of 2-HEA (as can been seen in the sections for repeated dose toxicity) the lower LD50 values from rabbit studies are assessed to be a secondary reaction due to severe local effects. Moreover, bioavailability after dermal application of non-corrosive test substance concentrations has been shown to be definitively lower than after oral administration (BAMM, 1992).
Although evaluation and classification of a test substance should be based on the most sensitive species, rabbits are assessed to be hypersensitive towards corrosive test substances causing severe skin damage and do not adequately reflect the acute dermal toxicity potential of such substances. Therefore, rabbits are considered to be inappropriate for the evaluation of dermal toxicity of 2-HEA and the respective studies are considered invalid (reliability 3).
In contrast, based on data from rats, even under test conditions at which the skin barrier is compromised and severe local tissue damage is noted, however in the absence of mortality, this species is assessed to be the most appropriate one for the evaluation of acute dermal toxicity of 2-HEA. Furthermore, the rat is one of the recommended test species according to OECD TG 402. It should be noted, that even in rats, the noted effects at necropsy (rather unspecific toxicity) might at least partially due to severe local skin damage caused by 2-HEA.
A retrospective analysis of data from acute oral and dermal toxicity testing, performed on pesticide active substances and new chemical entities has demonstrated that there is a relationship between dermal acute toxicity and oral acute toxicity, and there are no significant numbers of compounds that are classified as a potential hazard only via the dermal route (Creton et al. 2010). Thus, a comparable acute oral and dermal hazard can be expected.
This assessment is supported by data from acrylic acid (AA), one of the main metabolites of 2-HEA. For AA the situation regarding skin effects and acute dermal toxicity is comparable: skin corrosivity and pronounced acute dermal toxicity noted in rabbits based on results with undiluted material. A recently performed acute dermal toxicity study with diluted acrylic acid in rabbits shows however, that all animals survived exposure to the test substance up to the limit dose of 2000 mg/kg bw. At 2000 mg/kg (20% dilution) all animals survived and gained body weight as expected. From Day 1 through Day 14, animals were observed with areas of brown discoloration, blanching, edema, erythema, eschar, fissuring, mechanical damage and/or small areas of necrosis. Besides clear skin damage, no gross abnormalities were noted during the gross necropsy. These results clearly show that the pronounced toxic effects of acrylic acid and in consequence also 2-HEA are due to local corrosion/tissue damage, but not or only to a minor degree due to systemic toxicity (BAMM, 2011).
Inhalation exposure route:
Data on acute toxicity of 2-hydroxyethyl acrylate by the inhalation route are limited. There are several inhalation hazard tests available where groups of rats were exposed to vapour atmospheres saturated with the volatile parts of the substance. In one study groups of 3 rats/sex were exposed for 8 hrs to a vapour atmosphere and observed for a post-exposure period of 7 days. No mortality occurred, clinical signs of toxicity were dyspnoea and irritation of mucous membranes (nose, respiratory tract) (BASF, 1974).
Inhalation exposures to 333 and 394 ppm (corresponding to approx. 1.58 and 1.87 mg/L exceeding by far the saturated vapour concentration, indicating a vapour / aerosol mixture) for 8 and 4 hours respectively caused irritation and were in the threshold area for lethality. In both trials 1/6 rats died within 24 hrs of exposure to a saturated vapour atmosphere (Union Carbide Corporation, 1966a).
A 7-hour exposure to a saturated vapour atmosphere of approx. 300 ppm (corresponding to approx. 1.45 mg/L; exceeding by far the saturated vapour concentration, indicating a vapour / aerosol mixture) at room temperature had no lethal effect on 5 female Sherman rats. No signs of toxicity were observed. In parallel, 5 female rats were exposed to an atmosphere saturated with test substance vapours at 100 °C. 5/5 rats died within 5 hrs of exposure (Dow Chem. Co., 1980). Similar results were observed in another study by The Dow Chemical Company (1962).
Justification for classification or non-classification
Based on the available information the substance is classified as Acute Tox. 4 H302: Harmful if swallowed and Acute Tox. 4 H312: Harmful if in contact with skin, in accordance with EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.